James (Jim) Robinson is the vice chair of the Coalition for Epidemic Preparedness Innovations (CEPI).
Robinson manages the CEPI manufacturing strategy for a COVID-19 vaccine.
[1] Robinson began his career as a biochemical engineer with G.D. Searle and worked at various companies before becoming the head of technical support for Merck's vaccine, biologics and sterile manufacturing in 2010.
[2][3] In 2017, Robinson began serving on CEPI's scientific advisory board.
[3] On February 16, 2022, Robinson was awarded a two-year, $340,000 grant by the Arnold Ventures Foundation to study biosimilars to determine potential cost savings from wider use of them.